Format

Send to

Choose Destination
Am J Psychiatry. 2017 Jul 1;174(7):695-696. doi: 10.1176/appi.ajp.2017.17020239.

A Survey of the Clinical, Off-Label Use of Ketamine as a Treatment for Psychiatric Disorders.

Author information

1
From the Department of Psychiatry, Yale School of Medicine, New Haven, Conn.; Kaiser Permanente Northern California, San Francisco; and Ketamine Treatment Centers, Princeton, N.J.

KEYWORDS:

Epidemiology; Ketamine; Mood Disorders-Bipolar; Mood Disorders-Unipolar

PMID:
28669202
PMCID:
PMC5549850
DOI:
10.1176/appi.ajp.2017.17020239
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center